Drug shortages – everyone is talking about them, especially in the sterile injectable supply chain.

Shortages have attracted the unrelenting attention of industry publications, and are generating serious discussions at this year's conferences.

I am very pleased to be participating with other industry leaders during DCAT Week to discuss the unique challenges facing the sterile injectable supply chain. As part of a panel examining "Key Trends for Sterile Injectable Manufacturing and Outsourcing," we will discuss shortages, regulatory challenges and outsourcing trends in the injectable drug space.

I believe these challenges provide unique opportunities for contract manufacturers and drug sponsors to partner in new and collaborative ways. This is consistent with the type of CMO we strive to be, routinely leveraging the strengths of our people, facilities and processes to manage supply chains for our customers. It's something we've successfully done for years – and we look forward to sharing some "lessons learned" in upcoming newsletters.

If you're attending DCAT Week, please join the session "Key Trends for Sterile Injectable Manufacturing and Outsourcing," then visit with us during the networking reception that OsoBio is sponsoring Wednesday afternoon. It would be my pleasure to speak with you.

Milton Boyer
President

DCAT Week

DCAT Week remains one of OsoBio's favorite conferences of the year. As you know, Milton serves on the executive committee of DCAT. This year, he's a panelist examining key trends for sterile injectables, with a focus on how CMOs can improve operational security while retaining competitiveness. This panel is being held:

Wed., March 13
9 - 11:45 a.m.
Vanderbilt Room

OsoBio also sponsors the Wed. evening networking reception following the "Facilities of the Future" session. Will you be at DCAT Week? Let us know if we can expect to see you. You can find the agenda at DCAT.org.

Looking Ahead to Interphex in April

Policy recommendations for improving patient access to drugs in shortage is the subject of the conference keynote at Interphex on Tues., April 23. Plan ahead to schedule a meeting with us, or drop by our booth in the exhibit hall at booth #3682.

OsoBio guests can receive 50% off registration to the Interphex exhibit hall in the Javits Center; please follow this link to register at the discounted rate.

OsoBio is a CMO that specializes in delivering injectable sterile liquid, suspension and lyophilized biologic and pharmaceutical products. The company offers significant knowledge and experience in late-phase clinical products and successfully taking them to commercialization. www.OsoBio.com



	Examining Drug and Supply Shortages and Possible Solutions
Drug shortages – everyone is talking about them, especially in the sterile injectable supply chain. Shortages have attracted the unrelenting attention of industry publications, and are generating serious discussions at this year's conferences. I am very pleased to be participating with other industry leaders during DCAT Week to discuss the unique challenges facing the sterile injectable supply chain. As part of a panel examining "Key Trends for Sterile Injectable Manufacturing and Outsourcing," we will discuss shortages, regulatory challenges and outsourcing trends in the injectable drug space. I believe these challenges provide unique opportunities for contract manufacturers and drug sponsors to partner in new and collaborative ways. This is consistent with the type of CMO we strive to be, routinely leveraging the strengths of our people, facilities and processes to manage supply chains for our customers. It's something we've successfully done for years – and we look forward to sharing some "lessons learned" in upcoming newsletters. If you're attending DCAT Week, please join the session "Key Trends for Sterile Injectable Manufacturing and Outsourcing," then visit with us during the networking reception that OsoBio is sponsoring Wednesday afternoon. It would be my pleasure to speak with you. Milton Boyer President DCAT Week DCAT Week remains one of OsoBio's favorite conferences of the year. As you know, Milton serves on the executive committee of DCAT. This year, he's a panelist examining key trends for sterile injectables, with a focus on how CMOs can improve operational security while retaining competitiveness. This panel is being held: Wed., March 13 9 - 11:45 a.m. Vanderbilt Room OsoBio also sponsors the Wed. evening networking reception following the "Facilities of the Future" session. Will you be at DCAT Week? Let us know if we can expect to see you. You can find the agenda at DCAT.org. Looking Ahead to Interphex in April Policy recommendations for improving patient access to drugs in shortage is the subject of the conference keynote at Interphex on Tues., April 23. Plan ahead to schedule a meeting with us, or drop by our booth in the exhibit hall at booth #3682. OsoBio guests can receive 50% off registration to the Interphex exhibit hall in the Javits Center; please follow this link to register at the discounted rate. OsoBio is a CMO that specializes in delivering injectable sterile liquid, suspension and lyophilized biologic and pharmaceutical products. The company offers significant knowledge and experience in late-phase clinical products and successfully taking them to commercialization. www.OsoBio.com	CMO Leadership Award OsoBio's regulatory affairs and productivity will be recognized with two CMO Leadership Awards at DCAT Week. Read more. Customer Support Our people make the difference when it comes to managing supply of finished products and raw materials. Meet OsoBio's customer support team here. Connect with us
OsoBio \| 4401 Alexander Boulevard, NE \| Albuquerque, NM 87107 \| 505-923-2112 unsubscribe

DCAT Week

Looking Ahead to Interphex in April

CMO Leadership Award

Customer Support

Connect with us